GHRH analogue + GHS-R1a agonist blend

CJC-1295 + Ipamorelin

For research use only

Starting at $75 per vial

$75first month, then $75/mo

Checking availability…

Description

A two-component lyophilised research blend. CJC-1295 is a 30-amino-acid analogue of GHRH(1-29) bearing D-Ala2, Gln8, Ala15 and Leu27 substitutions that confer resistance to DPP-4 cleavage; molecular weight approximately 3367.9 Da. Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2), formula C38H49N9O5, molecular weight approximately 711.9 Da, acting as a selective agonist at the ghrelin receptor (GHS-R1a). In vitro the two compounds engage distinct receptor pathways - GHRH-R and GHS-R1a - and are studied together in somatotroph signalling assays. For laboratory research use only.

Batch testedThird-party verifiedLot documented

For research use only

These statements have not been evaluated by the Food and Drug Administration. Supplied strictly for in-vitro laboratory research. Not for human or veterinary use. Nothing on this site is medical advice or a statement about any health outcome. Individual research outcomes vary.

CJC-1295 + Ipamorelin research vial on travertine

Related compounds: Ipamorelin, MOTS-c

Lab tested for quality and potency

Every lot is released only after independent third-party testing. Certificates of analysis are available on request.

Purity · Science · Precision · Stability

The same standards on every lot

Third-party tested
>99% purity
Lyophilised
Batch numbered
COA on request
Sealed packaging
"Purity, handling and storage decide whether a result is repeatable. Everything else is downstream of how the vial was made and shipped."
From our handling and storage library

Other compounds in the catalog

Products shown are research peptides supplied for research use and are not evaluated by the FDA. Nothing here is medical advice.

CJC-1295 + Ipamorelin

From $75 per vial

  • No long-term contracts
  • Flat price per vial
  • Batch-tested purity
  • Tracked delivery

Checking availability…

Recurring orders can be cancelled any time before the next billing date.

Disclaimer

Research peptides are supplied for research use and are not evaluated by the FDA for safety, effectiveness or quality.

Supplied strictly for in-vitro laboratory research. Not for human or veterinary use. Nothing on this site is medical advice or a statement about any health outcome. Individual research outcomes vary.

Supporting studies

  1. Review of peptide stability and handling in laboratory settings, Journal of Placeholder Chemistry, 2021.
  2. Analytical verification of synthetic peptide identity, Placeholder Research Reports, 2022.
  3. Purity and potency profile of research-grade preparations, Journal of Placeholder Analysis, 2020.
  4. Analytical methods for peptide identity confirmation, Placeholder Research Review, 2023.
  5. Longitudinal review of lyophilised compound stability, Placeholder Research Annals, 2024.